Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions.
Pignatti F, Ashby D, Brass EP, Eichler HG, Frey P, Hillege HL, Hori A, Levitan B, Liberti L, Löfstedt RE, McAuslane N, Micaleff A, Noel RA, Postmus D, Renn O, Sabourin BJ, Salmonson T, Walker S. Pignatti F, et al. Among authors: levitan b. Clin Pharmacol Ther. 2015 Nov;98(5):522-33. doi: 10.1002/cpt.203. Epub 2015 Sep 11. Clin Pharmacol Ther. 2015. PMID: 26261064 Free article. Review.
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Spyropoulos AC, Lipardi C, Xu J, Lu W, Suh E, Yuan Z, Levitan B, Sugarmann C, De Sanctis Y, Spiro TE, Barnathan ES, Raskob GE. Spyropoulos AC, et al. Among authors: levitan b. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619886022. doi: 10.1177/1076029619886022. Clin Appl Thromb Hemost. 2019. PMID: 31746218 Free PMC article.
U.S. Food and Drug Administration's Patient-Focused Drug Development Initiative: Experience with Integration of Patient-Experience Data in a New Drug Application for Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant for Treatment-Resistant Depression.
Katz EG, McNulty P, Levitan B, Treichler P, Martynowicz J, Jamieson C. Katz EG, et al. Among authors: levitan b. Ther Innov Regul Sci. 2022 Jan;56(1):38-46. doi: 10.1007/s43441-021-00340-6. Epub 2021 Oct 8. Ther Innov Regul Sci. 2022. PMID: 34623613 Free PMC article.
130 results